Wolfson Institute of Preventive Medicine - Barts and The London

UKCOGS – UK COvid and Gynaecological Cancer Study

Barts Clinical Trials Unit, Wolfson Institute of Preventive Medicine, Queen Mary

Project Investigator:  Professor Ranjit Manchanda

Overview

The COVID-19 pandemic has created unprecedented changes in gynaecological cancer treatment delivery in the UK, with many aspects of the patient pathway affected and treatments prioritised and modified. The UK Covid and Gynaecological Cancer Study (UKCOGS) is a multi-phased project recording and assessing changes and outcomes in patient care across the patient pathway, within the multi-disciplinary team context.

Aims

  • To evaluate the MDT decision making for gynaecological cancer, patients outcomes across the UK in response to the COVID-19 pandemic.
  • To document the structural and logistic changes implemented across Gynae-oncology cancer centres in response to the COVID-19 pandemic.

The first phase of this project is a national audit of the impact of the COVID-19 pandemic on treatment recommendations for patients made through multi-disciplinary team (MDT) clinic meetings.

Hospital sites wishing to get involved, can download our UKCOGS expression of interest form [DOC 17KB] and UKCOGS study pack v3 [PDF 749KB].  When you have completed the expression of interest form please return it to bcc-ukcogs@qmul.ac.uk

Please see our UKCOGS Data Entry Guide [PDF 1,241KB] and the Psuedoanonymised Site File/wolfson/media/wolfson/UKCGOS_Pt-ID_Pseudo-anonymised_SiteFile_v3.xlsxfor further guidance.

The project is endorsed by the British Gynaecological Cancer Society (BGCS), Royal College of Obstetricians and Gynaecologists (RCOG), the NCRI Gynaecological Cancer Clinical Studies Group, the British Association of Gynaecological Pathologists (BAGP), The Eve Appeal, Target Ovarian Cancer, Ovarian Cancer Action, Ovacome, Jo’s Cervical Cancer trust and GO Girls

UKCOGS Co-Leads:

Ranjit Manchanda, Sadaf Ghaem-MaghamiSean Kehoe

 

 Logos of the organisations funding the UKCOGS study

Further Information

UKCOGS Steering Committee:

Dr Andy Nordin (Chair, Steering Committee, Consultant Gynaecological Oncologist, East Kent, Margate)

Dr Simon Leeson (Consultant Gynaecological Oncologist, North Wales Gynaecological Cancer Surgical Centre)

Dr Stephen Dobbs (Consultant Gynaecological Oncologist, Belfast Health and Social Care Trust)

Mr Kevin Burton (Consultant Gynaecological Oncologist, Glasgow Royal Infirmary)

Professor Sudha Sundar (BGCS President, Consultant Gynaecological Oncologist, Birmingham University)

Dr Shibani Nicum (Chair NCRI Gynae CSG, Consultant Medical Oncologist, University of Oxford)

Professor Glenn McCluggage (Consultant Histopathologist, BAGP, Queens University of Belfast)

Ms Helen Manderville (Clinical Nurse Specialist)

Dr Alex Taylor (Consultant Clinical Oncologist, Royal Marsden Hospital)

Professor Evis Sala (Consultant Radiologist, Addenbrookes Hospital, University of Cambridge)

Dr Adam Brentnall (Statistician, WIPM, Queen Mary University of London)

Professor Rhian Gabe (Director, Barts Clinical Trials Unit, WIPM, Queen Mary University of London)

Dr Rosa Legood (Health Economist, London School of Hygiene & Tropical Medicine)

Patient representative (TBC)

Professor Ranjit Manchanda (Wolfson Institue of Preventive Medicine, Queen Mary University of London)

Professor Sadaf Ghaem-Maghami (Imperial College)

Professor Sean Kehoe (Birmingham University)

Logos of the universities collaborating on the UKCOGS study

Staff

UKCOGS Co-Leads:

Professor Ranjit Manchanda (Wolfson Institue of Preventive Medicine, Queen Mary University of London)

Professor Sadaf Ghaem-Maghami (Imperial College)

Professor Sean Kehoe (Birmingham University)

Director Trials Unit:

Professor Rhian Gabe (Wolfson Institue of Preventive Medicine, Queen Mary University of London)

Statistician:

Dr Adam Brentnall (Wolfson Institue of Preventive Medicine, Queen Mary University of London)